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Abstract 
Objective: To evaluate complete blood count 
(CBC) changes that suggest coronavirus 
disease-2019 (COVID-19) among asymptomatic 
pregnant women attending routine antenatal 
care  
Methods: A cross-sectional study included 187 
healthy pregnant women who were attending the 
antenatal care clinic of a tertiary University 
hospital between March and June 2020. After a 
thorough history and examinations, a venous 
blood sample was taken from each participant 
for complete and differential blood counts. 
Those who showed CBC findings suggestive of 
COVID-19 were further scheduled for a 
nasopharyngeal swab for detection of SARS-
CoV-2 specific antigens through polymerase 
chain reaction (PCR). 
Results: We found 5.3% (n=10) of the study 
population showed CBC changes that are 
suggestive of COVID-19. When they were 
scheduled for nasopharyngeal swab for a PCR 
confirmatory test, 30% (n=3) of them were PCR 
positive (which represented 1.6% of the entire 
study population). The most frequently 
encountered COVID-19-suggestive change in 
peripheral blood leukocyte differential counts 
was leucopenia (100%), followed by decreased 
eosinophil count (50%), then neutropenia and 
lymphocytopenia (30%). 
Conclusions: Certain differential leucocyte 
count changes (leucopenia, neutropenia, 
lymphocytopenia and decreased eosinophil 
count) among asymptomatic pregnant women 
might be related to COVID-19 infection and may 
indicate a need for further testing. 
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Introduction 
Coronaviruses are a family of pathogens 
that can potentially infect both humans 
and animals. They produce several 
clinical entities such as the common 
cold, severe acute respiratory syndrome 
(SARS) and Middle East respiratory 
syndrome (MERS).1 The first known 
human-infecting coronaviruses were 
called 229E and OC43. They generally 
cause very mild infections. However, 
after more severe outbreaks of SARS 
and MERS, this virus family has 
received markedly increased attention 
and has been subject to extensive 
study.2 
A novel coronavirus was identified by 
the end of 2019 as the cause of several 
forms of pneumonia in Wuhan, Hubei 
Province of China, resulting in an 
epidemic throughout China. The 
pathogen was identified as severe acute 
respiratory syndrome coronavirus 2 
(SARS-CoV-2), and the disease was 
identified as coronavirus disease-2019 
(COVID-19). In March 2020, with the 
rapid worldwide spread across 
numerous countries, the COVID-19 
outbreak was declared a pandemic by 
the World Health Organization (WHO).3  
SARS-CoV-2 is an enveloped, positive-
stranded RNA virus with nucleocapsid. It 
is a beta coronavirus in the same 
subgenus as the severe acute 
respiratory syndrome (SARS) virus (as 
well as several bat coronaviruses). The 
receptor-binding gene region is very 
similar to that of the SARS coronavirus, 
and they were both found to use the 
same receptor for cell entry, the 
angiotensin-converting enzyme 2 
(ACE2) receptor.4 
COVID-19 presents with heterogeneous 
clinical features that markedly vary in 
severity. About 81% of cases present 
with mild disease. However, up to 14% 
of cases are moderate to severe and 
present with dyspnea, respiratory 
frequency ≥30/min, blood oxygen 
saturation (SpO2) ≤93%, and 
percentage of oxygen supplied (fraction 
of inspired oxygen, FiO2)] < 300, and/or 
lung infiltrates > 50% within 24 to 48 
hours.  Critical infections represent only 
5% of cases and include presentation as 
septic shock, respiratory failure and/or 
multiple organ failure.5  
The rate of infection with SARS-CoV-2 
in the study region at the time the study 
was conducted was underestimated. 
However, official reports claimed that it 
occurred in less than 1% of the 
population. Therefore, the current study 
aims to evaluate the complete blood 
count (CBC) changes that suggest 
COVID-19 infection among 
asymptomatic pregnant women 
attending routine antenatal care  
Materials and Methods 
This cross-sectional study was 
conducted at the antenatal care clinic of 
a tertiary University hospital between 
March and June 2020. All participants 
gave informed written consent before 
inclusion in the study. The study 
included 187 healthy pregnant females 
between the age of 18 and 40 years, 
irrespective of gestational age, who 
presented for routine antenatal care. 
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After informed consent had been 
obtained, all the study participants 
underwent detailed history taking, and 
general, chest, abdominal and local 
examinations. The aim of the detailed 
history and examinations was to assure 
the absence of any obstetric 
complications or chronic medical 
conditions. An emphasis was made 
during history taking and examinations 
to exclude any participant who were 
symptomatic for COVID-19 infection. 
The presence of any of the following: 
fever, dry cough, tiredness, muscle 
aches and pains, sore throat, diarrhea, 
conjunctivitis, headache, loss of taste or 
smell, skin rash, discoloration of fingers 
or toes, difficulty in breathing or 
shortness of breath, chest pain or 
deteriorated general condition, in the 
previous 14 days preceding enrollment 
in the study was taken as suggestive of 
COVID-19, and the participant was 
excluded from the study. 
After assuring proper inclusion of 
participants as previously detailed, a 
venous blood sample (3 mL, to K+EDTA 
containing tube) was taken from each of 
the participants for complete and 
differential blood counts, using an 
automated cell counter as well as 
stained peripheral blood smear 
microscopy, with emphasis on 
differential leucocyte count. The 
combination of any two of the following 
pathologies -- leucopenia, neutropenia, 
lymphocytopenia, decreased eosinophil 
count or monocytosis -- was taken as 
COVID-19-suggestive blood count 
changes.6,7  
The following reference values were 
used for the diagnosis of the 
aforementioned changes.8 This cross-
sectional study was conducted at the 
antenatal care clinic of a tertiary 
University hospital between March and 
June 2020. All participants gave 
informed written consent before 
inclusion in the study. The study 
included 187 healthy pregnant females 
between the age of 18 and 40 years, 
irrespective of gestational age, who 
presented for routine antenatal care. 
After informed consent had been 
obtained, all the study participants 
underwent detailed history taking, and 
general, chest, abdominal and local 
examinations. The aim of the detailed 
history and examinations was to assure 
the absence of any obstetric 
complications or chronic medical 
conditions. An emphasis was made 
during history taking and examinations 
to exclude any participant who were 
symptomatic for COVID-19 infection. 
The presence of any of the following: 
fever, dry cough, tiredness, muscle 
aches and pains, sore throat, diarrhea, 
conjunctivitis, headache, loss of taste or 
smell, skin rash, discoloration of fingers 
or toes, difficulty in breathing or 
shortness of breath, chest pain or 
deteriorated general condition, in the 
previous 14 days preceding enrollment 
in the study was taken as suggestive of 
COVID-19, and the participant was 
excluded from the study. 
After assuring proper inclusion of 
participants as previously detailed, a 
venous blood sample (3 mL, to K+EDTA 
containing tube) was taken from each of 
the participants for complete and 
Proceedings in Obstetrics and Gynecology, 2021;10(2):5 
 
COVID-19 and CBC changes in pregnancy  4 
 
differential blood counts, using an 
automated cell counter as well as 
stained peripheral blood smear 
microscopy, with emphasis on 
differential leucocyte count. The 
combination of any two of the following 
pathologies -- leucopenia, neutropenia, 
lymphocytopenia, decreased eosinophil 
count or monocytosis -- was taken as 
COVID-19-suggestive blood count 
changes.6,7  
The following reference values were 
used for the diagnosis of the 
aforementioned changes.8 Table 1 
Table 1. Polymerase Chain Reaction 
(PCR) for detection of SARS-CoV-2 
Type of cells  Absolute values 
Total leucocytes 4 to11×109/L 
Segmented neutrophils 2.4 to 7.5×109/L 
Lymphocytes 1 to 4.75 ×109/L 
Eosinophils 0.03 to 0.45×109/L 
Monocytes 0.1 to 0.7×109/L 
 
Participants who showed CBC changes 
suggestive of COVID-19 were 
scheduled for real- time PCR testing for 
detection of SARS-CoV-2 antigens. The 
test was done by obtaining a 
nasopharyngeal swab. Nucleic acid 
extraction from collected samples 
followed by RT-PCR assay using 
TaqMan One-Step RT-PCR protocol 
was performed. 
Follow up 
All the participants who showed COVID-
19-suggestive CBC changes, whether 
they were PCR positive or negative, 
were followed for 14 days for the 
presence of any symptoms suggestive 
of COVID-19 infection. Those who were 
PCR positive were isolated at home and 
given an appropriate treatment protocol 
for asymptomatic COVID-19 confirmed 
cases while those who were PCR 
negative were isolated at home and 
given health education about proper 
sanitation, diet, exercise and fluid 
intake.  
Results 
The study included 187 women with 
gestational ages ranging between 14 
and 36 weeks. The mean age of 
participants was 26.8 years, and none of 
them had any medical disorders. 
Indeed, 5.3% (n=10) of the study 
population showed CBC changes that 
were suggestive of COVID-19. When 
these patients were scheduled for 
nasopharyngeal swab as a PCR 
confirmatory test, 30 % (n=3) of them 
were PCR positive (which represented 
1.6% of the whole study population). 
Table 2 
Table 2. Frequency and percentage of 
participants who showed COVID-19-
suggestive CBC changes and PCR 
confirmed cases in relation to the 
overall study population  
 N(187) percentage 
Normal CBC 177 94.7% 
COVID-19 suggestive CBC 
changes 
10 5.3% 
PCR confirmed cases  3 1.6% 
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The mean total leucocyte count among 
those ten cases that showed COVID-19-
suggestive changes was 
3.7±0.26×109/L(3.2-4), while the mean 
neutrophil count was 
2.5±0.26×109/L(2.3-2.9). The mean 
lymphocytes count was 
0.98±0.13×109/L(0.8-1.2), while the 
mean eosinophil count was 
0.08±0.06×109/L(0.02-0.15). Table 3 
Table 3. Characteristics of peripheral 
blood leukocyte differential counts in 
participants who showed COVID-19-
suggestive changes 
 Mean±SD Range 
(min-max) 






Neutrophil count   
(X 109/L) 
2.5±0.26 (2.3-2.9) 
Eosinophil count   
(X 109/L) 
0.08±0.06 (0.02-0.15) 




The most frequently encountered 
COVID-19-suggestive change in 
peripheral blood leucocyte differential 
counts was leucopenia (100% of 
participants with CBC changes), 
followed by decreased eosinophil count 
(50%), then neutropenia and 
lymphocytopenia (each represented in 
30% of participants with CBC changes). 
Table 4 
 
Table 4. Frequency and percentage of 
differential leucocyte count changes 
among participants who showed 
COVID-19-suggestive CBC changes 
 Frequency  
(n=10) 
Percentage 
Leucopenia 10 100% 
Lymphopenia 3 30% 








When the 10 participants who showed 
COVID-19-suggestive differential blood 
count changes were followed for 
COVID-19 symptoms, three of them 
developed such symptoms 
(representing 30%). Two of the three 
were PCR positive, which meant that 
66.6% of the PCR positive 
asymptomatic pregnant participants 
developed symptoms later. On the other 
hand, one of the three participants who 
developed COVID-19 symptoms later 
tested PCR negative. Table 5 
Discussion 
Ever since the WHO has declared 
COVID-19 outbreaks to be pandemic, 
research worldwide has been mainly 
focused on the diagnosis and treatment 
of this disease.3 Initial reports came 
from Wuhan, Hubei Province of China, 
where the COVID-19 started. 
Subsequently, with the vast spread of 
the infection, reports of its spread came 
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from all over the world. From these 
reports it was evident that COVID-19 
represents a wide panel of 
presentations, ranging from 
asymptomatic cases to severe, life-
threatening conditions.5  
 
Table 5. Frequency and percentage of appearance of COVID-19 symptoms during 
the follow up period 
 Frequency of positive appearance of 
symptom during follow up 
Percentage 
Suggestive CBC with positive PCR (n=3) 2 20% 
Suggestive CBC with negative PCR (n=7) 1 10% 
Total  3 (n=10) 30% 
 
Discussion 
Ever since the WHO has declared 
COVID-19 outbreaks to be pandemic, 
research worldwide has been mainly 
focused on the diagnosis and treatment 
of this disease.3 Initial reports came 
from Wuhan, Hubei Province of China, 
where the COVID-19 started. 
Subsequently, with the vast spread of 
the infection, reports of its spread came 
from all over the world. From these 
reports it was evident that COVID-19 
represents a wide panel of 
presentations, ranging from 
asymptomatic cases to severe, life-
threatening conditions.5  
Several differential leucocyte count 
changes have been identified in 
conjunction with the diagnosis of 
COVID-19, including leucopenia, 
neutropenia, lymphocytopenia, 
decreased eosinophil count and 
monocytosis. However, the previous 
changes were not constant throughout 
patients, who presented with variable 
combinations of the abovementioned 
changes.6,7  
Khartabil et al., 2020 performed a 
systematic review representing a 
summary of the diagnostic and 
prognostic value of hemocytometry 
markers in COVID-19 patients. This 
summary included analysis of 250 
articles that were published between 
December 2019 and May 2020. The 
authors concluded that leucopenia, 
lymphcytopenia and an elevated 
neutrophil/lymphocyte ratio are the most 
consistent abnormal hemocytometric 
findings in patients with COVID-19, and 
that these alterations may be present at 
any time during the course of the 
disease, even in confirmed 
asymptomatic cases, with a tendency to 
marked alteration in severe cases.9  
Such a view that even asymptomatic 
patients may show CBC changes was 
confirmed by Yan Ma et al., 2020. They 
concluded that leucopenia was present 
in 27.1% of confirmed asymptomatic 
COVID-19 patients and that neutropenia 
was present in 9.1% of confirmed 
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asymptomatic COVID-19 patients.10  
Thus, these previous reports confirmed 
that certain changes in differential 
leucocyte count are a constant feature 
in COVID-19 patients, and that such 
changes are present even in confirmed 
asymptomatic patients. CBC is an 
essential investigation in routine 
antenatal care and pregnant females 
are considered a higher risk group for 
COVID-19. In this study, we interpreted 
early detection of the presence of CBC 
changes as suggesting COVID-19 
infection among asymptomatic pregnant 
females coming for routine antenatal 
care. With this goal in mind, we 
correlated these COVID-19 suggestive 
changes with the presence or absence 
of confirmed disease. 
In our study, ten women showed CBC 
changes that are suggestive of COVID-
19, and were scheduled for a 
nasopharyngeal swab for a PCR 
confirmatory test. Of these 10 women, 
30% (n=3) of them were PCR positive 
(which represented 1.6% of the whole 
study population). This finding suggests 
the importance of leucocyte differential 
count results as support for early 
diagnosis of COVID-19 among 
asymptomatic pregnant females during 
this pandemic era, as 30% of 
asymptomatic pregnant females with 
CBC findings suggestive of COVID-19 
changes were found to have confirmed 
disease (were PCR positive). 
The mean total leucocyte count among 
those ten cases that showed COVID-19 
suggestive changes denoted mild 
leucopenia. Of note, the CBC 
suggestive COVID-19 changes that we 
found in this research are compatible 
with Li et al., where they concluded that 
COVID-19 patients showed relatively 
lower absolute white blood cell (WBC) 
count 4.95(3.90,6.03)×10(9)/L, 
lymphocyte absolute count 
1.20(0.98,1.50)×10(9)/L and eosinophil 
absolute count 0.01(0.01,0.01)×10(9)/L.6 
In the present study, the most frequently 
encountered COVID-19 suggestive 
change in peripheral blood leucocyte 
differential counts was leucopenia 
(100%), followed by decreased 
eosinophil count (50%), then 
neutropenia and lymphocytopenia 
(30%). In the Fan et al., study, 
leucopenia was observed in 29.2% of 
patients, while lymphocytopenia 
featured in 36.9% of patients.7 Li et al., 
noted that leucopenia was observed in 
20% of patients, lymphocytopenia was 
featured in 20% of patients, while 
decreased eosinophil count was noted 
in 70% of cases.6 
The differences between the findings in 
differential leukocyte count in this study 
and other studies came from the fact 
that other studies concluded their results 
from the study of CBC of COVID-19 
confirmed patients, while our study 
started with the investigation of COVID-
19 suggestive CBC changes prior to 
confirmation of infection. When the ten 
participants who showed COVID-19 
suggestive differential leucocyte count 
changes were followed for COVID-19 
symptoms, three of them developed 
such symptoms (representing 30%). 
Notably, two of the three were PCR 
positive, which meant that 66.6% of the 
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PCR positive asymptomatic pregnant 
participants developed symptoms at a 
later phase of the infection. On the other 
hand, the one of the three participants 
who developed COVID-19 symptoms 
later was PCR negative, and when the 
PCR was repeated after appearance of 
symptoms, it was found to be positive, 
indicating that CBC changes suggestive 
of COVID-19 may even have a role in 
diagnosis of PCR negative cases. 
This idea is consistent with Zhou et al., 
where they followed 13 asymptomatic 
confirmed COVID-19 cases for two 
weeks. They noted the presence of 
leucopenia in 15.4% of cases while 
23.1% developed symptoms within two 
days following admission.11  
Given that the findings of this study are 
so small (n=3) as to be more anecdotal 
than statistically significant, they still 
pose some interesting questions for 
future research.  In fact, 100% of 
patients that showed leucopenia, 
decreased eosinophil count, 
neutropenia or lymphocytopenia 
eventually tested positive for COVID-19 
using PCR.  If these findings can be 
replicated in a substantially larger 
population, they may show that COVID-
19-suggestive changes in differential 
blood counts may allow physicians 
identify asymptomatic COVID-19 
patients, especially those with nascent 
disease or those who have verified 
exposures to the disease, more rapidly 
than is possible with existing PCR 
testing. 
 
Limitations of the study 
One of the main limitations of the study 
was the small number of women 
included. Furthermore, it would have 
been better if we had performed PCR 
testing for the entire study population as 
it would have given us a precise 
estimation of the prevalence of COVID-
19 among asymptomatic pregnant 
females coming for routine antenatal 
care. However, the regional protocol at 
the time of this study offered PCR 
testing only for symptomatic patients. In 
addition, replication of this study with a 
larger population would have further 
confirmed the role of changes in 
differential blood counts as predictors of 
nascent COVID-19. 
Conclusions 
Certain differential leucocyte count 
changes (leucopenia, neutropenia, 
lymphocytopenia and decreased 
eosinophil count) among asymptomatic 
pregnant women might be related to 
COVID-19 infection and, as such, they 
may be useful predictors of the need for 
further testing.   
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